| Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. | |
| | |
MedLine Citation:
|
PMID: 22377247 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Background/Aim: Oxidative stress (OS) is involved in left ventricular hypertrophy (LVH). Short-term treatment with erythropoietin (EPO) in chronic kidney disease (CKD) complicated by anemia and LVH is associated with a reduction in left ventricular mass (LVM). We proposed to assess whether the pro-oxidant status of CKD influences these outcomes. Methods: Predialysis patients (n = 76) with CKD and hemoglobin (Hb) levels < 11 g/dl received EPO for 6 months. The effects of this anemia correction on LVH regression were evaluated using echocardiography. Patients with LVM decrease > 10% were considered "responders" (n = 25) to treatment and those with LVM change < 10% were considered "non-responders" (n = 24). Measurement of OS included plasma and erythrocyte oxidized (GSSG) and reduced (GSH) glutathione, GSH redox ratio (GSSG/GSH), erythrocyte glutathione peroxidase (GPx) and oxidized LDL (Ox- LDL). Results: 49 patients completed the study. With EPO therapy, mean Hb levels increased from 9.9 ± 0.6 to 12.8 ± 1.5 g/ dl (p < 0.0001) and LVM index decreased from 69.2 ± 17.7 to 64.1 ± 19.6 g/m2.7 (p = 0.01). At 6 months, "non-responders" had higher systolic blood pressure, pulse pressure, GSSG and GSH redox ratio and lower GSH than "responders". In multivariate analysis, and following adjustment for confounding variables, systolic blood pressure and GSH redox ratio independently predicted LVH regression. Conclusion: Blood pressure and plasma GSH redox ratio (a marker of OS) are important predictors of LVH regression in anemic predialysis patients treated with EPO. |
| | |
Authors:
|
Alberto Martinez-Vea; Luis Marcas; Alfredo Bardají; Marta Romeu; Cristina Gutierrez; Carmen García; Teresa Compte; Rosa Nogues; Carmen Peralta; Montserrat Giralt |
Related Documents
:
|
15811867 - Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and l... 17287367 - Ros scavenging before 27 degrees c ischemia protects hearts and reduces mitochondrial r... 10509357 - A limited interval of delayed modest hypothermia for ischemic brain resuscitation is no... 9205547 - Short-term inhibition of the na-h exchanger limits acidosis and reduces ischemic injury... 6498577 - Effect of halogenated anaesthetics on heart rate changes during reversal of neuromuscul... 11371487 - Ocular pulse amplitude is reduced in patients with advanced retinitis pigmentosa. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical nephrology Volume: 77 ISSN: 0301-0430 ISO Abbreviation: Clin. Nephrol. Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-03-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0364441 Medline TA: Clin Nephrol Country: Germany |
Other Details:
|
Languages: eng Pagination: 171-81 Citation Subset: IM |
Affiliation:
|
Nephrology Service, Cardiology Service, Research Unit, of the Hospital Universitari de Tarragona Joan XXIII, IISPV, Pharmacology Unit, Department of Basic Medical Sciences, Universitat Rovira i Virgili, Tarragona, and Nephrology Assistance Unit, Hospital de Jesús, Tortosa, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Influence of hospital location on short-term fate of premature infants born at 34 weeks of gestation...
Next Document: Is the sodium level per se related to mortality in hospitalized patients with severe hyponatremia?